NCT04627532View on ClinicalTrials.gov

Single Ascending Dose Study of Intravenous Infusion of PF 07304814 in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 23, 2020

Primary Completion Date

December 17, 2020

Study Completion Date

December 17, 2020

Conditions
Healthy
Interventions
DRUG

PF-07304814

Participants will receive PF-07304814

DRUG

Placebo

Participants will recieve placebo

Trial Locations (1)

06511

New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04627532 - Single Ascending Dose Study of Intravenous Infusion of PF 07304814 in Healthy Adult Participants | Biotech Hunter | Biotech Hunter